Rituxan (rituximab) – PML
Audience: Rheumatological healthcare professionals
Genentech and FDA notified healthcare professionals about a third case of progressive multifocal leukoencephalopathy [PML], the first case of PML in a patient with rheumatoid arthritis [RA]…



No related posts.